Johnson & Johnson (JNJ)

← Back

JNJ

Johnson & Johnson

Sector: Healthcare Industry: Drug Manufacturers - General
$242.16
-0.64%
Thesis

Company Overview

jnj.com

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

138,200 employees
IPO: 1944-09-24
USA

Fundamental Snapshot

Company Info

Market Cap $587,316.5M
Enterprise Value $612,448.4M
Revenue TTM $94,193.0M
EBITDA $33,836.0M
Shares Out 2,409.9M
Float 2,406.1M

Valuation

P/E Ratio 22.1x
Forward P/E 21.0x
P/S Ratio 6.24x
P/B Ratio 7.17x
EV/EBITDA 14.9x
PEG Ratio 1.70

Profitability

Gross Margin 68.1%
Operating Margin 24.0%
Net Margin 28.5%
ROE 35.0%
ROA 8.7%
EPS TTM $11.04

Risk / Health

Debt/Equity 0.59
LT Debt/Equity 0.48
Current Ratio 1.03
Quick Ratio 0.77
Debt/EBITDA 1.4x
Piotroski F-Score 6
Altman Z-Score 5.20
Beneish M-Score -2.52

Price (1Y)

$243.71
50 SMA
$227.92 (+6.9%)
200 SMA
$189.10 (+28.9%)
52W High
$248.56 (-2.0%)
52W Low
$81.08 (+200.6%)

Revenue Growth (YoY)

9.1%

Revenue CAGR (3Y)

1.2%

Revenue CAGR (5Y)

1.8%

Earnings CAGR (3Y)

13.3%

FCF CAGR (3Y)

11.2%

FCF CAGR (5Y)

1.8%

Industry Benchmark: Drugs (Pharmaceutical)

228 firms | Source: Damodaran

PE (Current)

335.3x

PE (Forward)

24.2x

P/S

5.63x

EV/EBITDA

15.2x

ROE

24.0%

Net Margin

18.5%

Financial Metrics (Quarterly)

Income & Cash Flow

Revenue ($B)

Gross Profit ($B)

Operating Income ($B)

Net Income ($B)

Free Cash Flow ($B)

Op. Cash Flow ($B)

Expenses

Cost of Revenue ($B)

Operating Expenses ($B)

R&D Expense ($B)

SG&A Expense ($B)

Cash & Debt

Cash & Equivalents ($B)

Total Debt ($B)

Net Debt ($B)

Shareholders' Equity ($B)

Shares, Dividends & Valuation

Shares Outstanding (B)

Dividends Paid ($B)

P/E Ratio

P/S Ratio

EV/EBITDA

Segment KPIs

Coming soon - custom metrics from company filings